Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate.

BACKGROUND The Mediterranean dietary pattern is thought to reduce the risk of cancer in addition to being cardioprotective. However, no trial has been conducted so far to prove this belief. METHODS We compared overall survival and newly diagnosed cancer rate among 605 patients with coronary heart disease randomized in the Lyon Diet Heart Study and following either a cardioprotective Mediterranean-type diet or a control diet close to the step 1 American Heart Association prudent diet. RESULTS During a follow-up of 4 years, there were a total of 38 deaths (24 in controls vs 14 in the experimental group), including 25 cardiac deaths (19 vs 6) and 7 cancer deaths (4 vs 3), and 24 cancers (17 vs 7). Exclusion of early cancer diagnoses (within the first 24 months after entry into the trial) left a total of 14 cancers (12 vs 2). After adjustment for age, sex, smoking, leukocyte count, cholesterol level, and aspirin use, the reduction of risk in experimental subjects compared with control subjects was 56% (P=.03) for total deaths, 61% (P=.05) for cancers, and 56% (P=.01) for the combination of deaths and cancers. The intakes of fruits, vegetables, and cereals were significantly higher in experimental subjects, providing larger amounts of fiber and vitamin C (P<.05). The intakes of cholesterol and saturated and polyunsaturated fats were lower and those of oleic acid and omega-3 fatty acids were higher (P<.001) in experimental subjects. Plasma levels of vitamins C and E (P<.05) and omega-3 fatty acids (P<.001), measured 2 months after randomization, were higher and those of omega-6 fatty acids were lower (P<.001) in experimental subjects. CONCLUSIONS This randomized trial suggests that patients following a cardioprotective Mediterranean diet have a prolonged survival and may also be protected against cancer. Further studies are warranted to confirm the data and to explore the role of the different lipids and fatty acids in this protection.

[1]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[2]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[3]  M. de Lorgeril,et al.  Cretan Mediterranean diet for prevention of coronary heart disease. , 1995, The American journal of clinical nutrition.

[4]  C. Bain,et al.  Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. , 1995, Journal of the National Cancer Institute.

[5]  H. Neumann,et al.  Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. , 1993, The New England journal of medicine.

[6]  A. Gotto,et al.  Diet and health. , 1984, The Western journal of medicine.

[7]  D. Steinberg,et al.  Role of oxidised low density lipoprotein in atherogenesis. , 1993, British heart journal.

[8]  C. la Vecchia,et al.  Fruit and vegetable consumption and cancer risk in a Mediterranean population. , 1995, The American journal of clinical nutrition.

[9]  G. Block,et al.  Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. , 1992, Nutrition and cancer.

[10]  P. Touboul,et al.  Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease , 1994, The Lancet.

[11]  T A Colacchio,et al.  A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. , 1994, The New England journal of medicine.

[12]  P. Touboul,et al.  Effect of a mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments. , 1996, Journal of the American College of Cardiology.

[13]  A. Marcus.  Aspirin as prophylaxis against colorectal cancer. , 1995, The New England journal of medicine.

[14]  Ancel Keys.  Coronary heart disease in seven countries. , 1971, The Medical journal of Australia.

[15]  C. von Schacky,et al.  Dietary omega-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. , 1993, Blood.

[16]  D. Steinberg,et al.  Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Blackburn,et al.  The 7 countries study: 2289 deaths in 15 years , 1984 .

[18]  D. Steinberg,et al.  Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. , 1991, The American journal of clinical nutrition.

[19]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[20]  A. Leaf.  Cardiovascular effects of fish oils. Beyond the platelet. , 1990, Circulation.

[21]  J. Barthélémy,et al.  Control of bias in dietary trial to prevent coronary recurrences: The Lyon diet heart study , 1997, European Journal of Clinical Nutrition.

[22]  D. Klurfeld.  Dietary fiber-mediated mechanisms in carcinogenesis. , 1992, Cancer research.

[23]  W. T. Cave,et al.  Dietary n‐3 (ω‐3) polyunsaturated fatty acid effects on animal tumorigenesis , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  W. Willett,et al.  Diet and health: what should we eat? , 1994, Science.

[25]  T. Byers,et al.  Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. , 1992, Annual review of nutrition.

[26]  H. Rasmussen,et al.  Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. , 1993, The Journal of clinical investigation.

[27]  J. Manson,et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.

[28]  L. Marnett.  Aspirin and the potential role of prostaglandins in colon cancer. , 1992, Cancer research.